473 related articles for article (PubMed ID: 26426943)
41. A More Efficient Causal Mediator Model Without the No-Unmeasured-Confounder Assumption.
Brandt H
Multivariate Behav Res; 2020; 55(4):531-552. PubMed ID: 31497999
[TBL] [Abstract][Full Text] [Related]
42. Sensitivity analysis for unobserved confounding of direct and indirect effects using uncertainty intervals.
Lindmark A; de Luna X; Eriksson M
Stat Med; 2018 May; 37(10):1744-1762. PubMed ID: 29462839
[TBL] [Abstract][Full Text] [Related]
43. Mediation Analysis: A Practitioner's Guide.
VanderWeele TJ
Annu Rev Public Health; 2016; 37():17-32. PubMed ID: 26653405
[TBL] [Abstract][Full Text] [Related]
44. Estimating controlled direct effects in the presence of intermediate confounding of the mediator-outcome relationship: Comparison of five different methods.
Lepage B; Dedieu D; Savy N; Lang T
Stat Methods Med Res; 2016 Apr; 25(2):553-70. PubMed ID: 23070596
[TBL] [Abstract][Full Text] [Related]
45. Interpreting treatment-effect estimates with heterogeneity and choice: simulation model results.
Brooks JM; Fang G
Clin Ther; 2009 Apr; 31(4):902-19. PubMed ID: 19446162
[TBL] [Abstract][Full Text] [Related]
46. Implications of M bias in epidemiologic studies: a simulation study.
Liu W; Brookhart MA; Schneeweiss S; Mi X; Setoguchi S
Am J Epidemiol; 2012 Nov; 176(10):938-48. PubMed ID: 23100247
[TBL] [Abstract][Full Text] [Related]
47. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.
Li Y; Lee Y; Wolfe RA; Morgenstern H; Zhang J; Port FK; Robinson BM
Stat Med; 2015 Mar; 34(7):1150-68. PubMed ID: 25546152
[TBL] [Abstract][Full Text] [Related]
48. Introduction to causal diagrams for confounder selection.
Williamson EJ; Aitken Z; Lawrie J; Dharmage SC; Burgess JA; Forbes AB
Respirology; 2014 Apr; 19(3):303-11. PubMed ID: 24447391
[TBL] [Abstract][Full Text] [Related]
49. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
McCandless LC; Somers JM
Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
[TBL] [Abstract][Full Text] [Related]
50. On model selection and model misspecification in causal inference.
Vansteelandt S; Bekaert M; Claeskens G
Stat Methods Med Res; 2012 Feb; 21(1):7-30. PubMed ID: 21075803
[TBL] [Abstract][Full Text] [Related]
51. Unmeasured confounding in pharmacoepidemiology.
Groenwold RH; de Groot MC; Ramamoorthy D; Souverein PC; Klungel OH
Ann Epidemiol; 2016 Jan; 26(1):85-6. PubMed ID: 26559329
[No Abstract] [Full Text] [Related]
52. Bounding formulas for selection bias.
Huang TH; Lee WC
Am J Epidemiol; 2015 Nov; 182(10):868-72. PubMed ID: 26519426
[TBL] [Abstract][Full Text] [Related]
53. Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders.
Vanderweele TJ; Arah OA
Epidemiology; 2011 Jan; 22(1):42-52. PubMed ID: 21052008
[TBL] [Abstract][Full Text] [Related]
54. Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses.
Franklin JM; Eddings W; Glynn RJ; Schneeweiss S
Am J Epidemiol; 2015 Oct; 182(7):651-9. PubMed ID: 26233956
[TBL] [Abstract][Full Text] [Related]
55. Assessing the sensitivity of regression results to unmeasured confounders in observational studies.
Lin DY; Psaty BM; Kronmal RA
Biometrics; 1998 Sep; 54(3):948-63. PubMed ID: 9750244
[TBL] [Abstract][Full Text] [Related]
56. Effect decomposition in the presence of an exposure-induced mediator-outcome confounder.
Vanderweele TJ; Vansteelandt S; Robins JM
Epidemiology; 2014 Mar; 25(2):300-6. PubMed ID: 24487213
[TBL] [Abstract][Full Text] [Related]
57. Identification and robust estimation of swapped direct and indirect effects: Mediation analysis with unmeasured mediator-outcome confounding and intermediate confounding.
Tai AS; Lin SH
Stat Med; 2022 Sep; 41(21):4143-4158. PubMed ID: 35716042
[TBL] [Abstract][Full Text] [Related]
58. Sensitivity analysis for interactions under unmeasured confounding.
Vanderweele TJ; Mukherjee B; Chen J
Stat Med; 2012 Sep; 31(22):2552-64. PubMed ID: 21976358
[TBL] [Abstract][Full Text] [Related]
59. Within-Subject Mediation Analysis in AB/BA Crossover Designs.
Josephy H; Vansteelandt S; Vanderhasselt MA; Loeys T
Int J Biostat; 2015 May; 11(1):1-22. PubMed ID: 25849799
[TBL] [Abstract][Full Text] [Related]
60. Simulation study of instrumental variable approaches with an application to a study of the antidiabetic effect of bezafibrate.
Cai B; Hennessy S; Flory JH; Sha D; Ten Have TR; Small DS
Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():114-20. PubMed ID: 22552986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
